Kenox carves out a niche in orally inhaled and nasal drug product (OINDP) development. As a highly innovative contract development organization, we specialize in transforming promising molecules into effective drug-device combination products (OINDPs or Opthalmics). Our expertise seamlessly guides clients through every stage of the development; from early R&D and IND-enabling activities to small-scale clinical batch manufacturing, as illustrated in the flowchart. This "one-stop-shop" approach streamlines the process, reduces complexity, and accelerates timelines, bringing your product to the clinic faster.
Kenox intimately understands the specific needs and priorities of innovator companies. We tailor bespoke solutions and phase-appropriate development strategies, propelling your programs swiftly towards their next value inflection points. This collaborative approach ensures rapid and efficient advancement, maximizing your program's potential for success.